HIV Therapy and Diabetes Risk
- 1 June 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (6), 1267-1268
- https://doi.org/10.2337/dc08-0459
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected PatientsDiabetes Care, 2008
- Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adultsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- New Drugs and Diabetes Risk: Antipsychotic and Antiretroviral AgentsPublished by Elsevier BV ,2006
- Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus in the Multicenter AIDS Cohort StudyArchives of Internal Medicine, 2005
- A Structural Basis for the Acute Effects of HIV Protease Inhibitors on GLUT4 Intrinsic ActivityJournal of Biological Chemistry, 2004
- Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cellsJournal of Endocrinology, 2004
- Insulin Resistance in HIV Protease Inhibitor–Associated DiabetesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998